Home NDC 0093-2180 Liothyronine Sodium
Product NDC 0093-2180
11-digit product format 000932180
Labeler code 0093
Product ID 0093-2180_22ed1e76-c20a-481e-bc00-2b531d14c3e4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Liothyronine Sodium
Dosage form TABLET
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA211510
Marketing category ANDA
Marketing start 2021-02-26
Substance LIOTHYRONINE SODIUM
Active strength 50 ug/1
Pharmacologic classes Triiodothyronine [CS], l-Triiodothyronine [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211510-001 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 A211510-002 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 A211510-003 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211510-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2018-10-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211510-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2018-10-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A211510-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2018-10-26 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 111 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Liothyronine Sodium
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LIOTHYRONINE SODIUM 50 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination GCA9VV7D2N Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 903456 Internal RxNorm lookup 903697 Internal RxNorm lookup 903703 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-2180-01 Liothyronine Sodium 100 in 1 BOTTLE TABLET 100 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-2180 LIOTHYRONINE SODIUM TABLET [TEVA PHARMACEUTICALS USA, INC.] 3 Current NDC, Legacy NDC, 1 package rows 20210227_548d684a-86f5-4e57-9844-d8cf0a84e068.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0093-2180-01 00093218001 100 TABLET in 1 BOTTLE (0093-2180-01) 100 tablet 2021-02-26 0000-00-00 No No Current